DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
<p><strong>Aim.</strong> To evaluate the association of serum resistin with morphological and functional indices of hypertrophic myocardium in patients with type 2 diabetes and chronic heart failure (CHF) with preserved left ventricular ejection fraction.</p><p><stro...
Main Authors: | An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/214 |
Similar Items
-
The modern view on diabetic cardiomyopathy
by: P. Kh. Dzhanashiya, et al.
Published: (2010-04-01) -
DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
by: An. A. Aleksandrov, et al.
Published: (2015-09-01) -
THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION
by: R. P. Myasnikov, et al.
Published: (2015-10-01) -
The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities
by: E. A. Mershina, et al.
Published: (2015-12-01) -
Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists
by: M. D. Smirnova, et al.
Published: (2007-12-01)